(Q33817474)

29 July 2017

0 references

Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States (English)

1 reference

29 July 2017

0 references

United States of America

0 references

1 reference

1

Thomas P Monath

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

American Journal of Tropical Medicine and Hygiene

29 July 2017

published in

1 reference

29 July 2017

volume

82

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

919-921

1 reference

The use of yellow fever virus modified by in vitro cultivation for human immunization

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Viscerotropic disease following yellow fever vaccination in Peru

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Adverse event reports following yellow fever vaccination

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Acute viscerotropic disease following vaccination against yellow fever

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

History of thymoma and yellow fever vaccination

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861370

10.4269/AJTMH.2010.10-0001

30 October 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference